James Mahon
Impact in
- Pharmacy top 5%
- Infant Health and Development
-
- Diabetes Management and Research
- Diabetes Treatment and Management
Papers in
- Oncology 5
- Co-authors
- Angela Boland (15 shared papers)Y Dündar (9 shared papers)Sophie Beale (13 shared papers)Nick Hex (3 shared papers)Eleanor Kotas (11 shared papers)Mike Baxter (2 shared papers)Chris Bartlett (1 shared paper)Yevgeniy Samyshkin (1 shared paper)
- Journals
- Health Technology Assessment (8 papers)BMJ Open (2 papers)Diabetic Medicine (2 papers)International Journal of Medical Informatics (1 paper)PharmacoEconomics (1 paper)
- Partner nations
- United KingdomUnited StatesNetherlands
In The Last Decade
James Mahon
28 papers receiving 545 citations
Peers
Comparison fields: 5 of 95
- Pharmacy 45
- Endocrinology, Diabetes and Metabolism 109
- Immunology and Allergy 37
- Family Practice 12
- Gastroenterology 27
Countries citing papers authored by James Mahon
This map shows the geographic impact of James Mahon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Mahon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Mahon more than expected).
Fields of papers citing papers by James Mahon
This network shows the impact of papers produced by James Mahon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Mahon. The network helps show where James Mahon may publish in the future.
Co-authors
The 25 scholars most cited alongside James Mahon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 99 | |
| 2 | 2015 | 56 | |
| 3 | 2012 | 54 | |
| 4 | 2017 | 44 | |
| 5 | 2020 | 33 | |
| 6 | 2017 | 33 | |
| 7 | 2014 | 29 | |
| 8 | 2016 | 26 | |
| 9 | 2016 | 24 | |
| 10 | 1998 | 24 | |
| 11 | 2019 | 22 | |
| 12 | 2019 | 17 | |
| 13 | 2020 | 17 | |
| 14 | Pembrolizumab for untreated PD-L1 positive metastatic non-small cell lung cancer | 2016 | 14 |
| 15 | 2022 | 12 | |
| 16 | 2014 | 10 | |
| 17 | 2016 | 9 | |
| 18 | 2016 | 8 | |
| 19 | 2018 | 7 | |
| 20 | 2023 | 6 |
About James Mahon
James Mahon is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Epidemiology, Surgery and Endocrinology, Diabetes and Metabolism, having authored 33 papers that have together received 568 indexed citations. Recurring topics across this work include Diabetes Management and Research (4 papers), Diabetes Treatment and Management (3 papers), Child Nutrition and Feeding Issues (2 papers), Glaucoma and retinal disorders (2 papers), Cardiac Arrhythmias and Treatments (2 papers), Infant Health and Development (2 papers), Cardiac electrophysiology and arrhythmias (2 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers). The work is most often cited by research in Pharmacy (45 citations), Endocrinology, Diabetes and Metabolism (109 citations), Immunology and Allergy (37 citations), Family Practice (12 citations) and Gastroenterology (27 citations). James Mahon has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Angela Boland, Y Dündar, Sophie Beale, Nick Hex, Eleanor Kotas, Mike Baxter, Chris Bartlett, Yevgeniy Samyshkin, Nigel Fleeman and Julie Glanville. Their work appears in journals such as Health Technology Assessment, BMJ Open, Diabetic Medicine, International Journal of Medical Informatics and PharmacoEconomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.